Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned.
about
Arterial Therapies of Non-Colorectal Liver MetastasesWell-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapiesConsensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.Pancreastatin predicts survival in neuroendocrine tumors.The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome.Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors.Multimodal management of neuroendocrine liver metastases.Primary carcinoid tumour of the liver in a young Filipino female.Therapeutic pulmonary artery stenting for metastatic bronchial carcinoid.Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institutionTransarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review.Transarterial chemoembolization and selective internal radiation for the treatment of patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost.Hepatic primary neuroendocrine carcinoma: about a new caseEastern Canadian Gastrointestinal Cancer Consensus Conference 2014.A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors.Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.Therapeutic strategies for neuroendocrine liver metastases.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Telotristat ethyl: a new option for the management of carcinoid syndrome.Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors.Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes.Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes.Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma.Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response.Liver transarterial embolizations in metastatic neuroendocrine tumors.
P2860
Q26764990-43416976-96F7-4F53-8E07-F53B5F5CBCE4Q33840177-C097DA40-E1A7-4265-87A8-DB5E5B37B7C7Q33894587-B21749B1-29F4-4254-900C-670B59AE2C3FQ34016884-4B648281-ED52-4473-87D8-A071AF732C2BQ34031906-5933E711-B784-41EA-B74D-4B3790E4E67FQ34452319-F8868589-4ED3-4023-B4EB-87BD86F2E1B2Q34528199-3B35A160-8D8F-434C-8792-95E1D844CC77Q34710457-EF6C89B3-E662-4FF0-9BF7-F3EC6A542899Q34998070-3EF4B968-6C1B-43C7-8C62-9253683BDD08Q35018379-ACDCBEB5-CFE9-480B-8D32-CD386903EA98Q35579073-5FD97204-B48C-4C08-B54F-5C3BCF7D6DB4Q35584891-399BA53D-6DA6-4271-9BD3-9D6DCF9E6D41Q35793268-60DD43D2-C4D1-4B7F-A4BC-BB731933D3C3Q35934322-9AE9C2C0-1568-47FE-8B90-4B4FAAACC5ABQ36027379-7B7AA994-BB57-4152-9ACF-B01511F6C678Q36980633-95EDF52E-95B1-4AE1-BB25-5B24BF6A8AA7Q38019461-98050DBF-114A-4BA2-BA8D-8EA44905FC4CQ38255979-43BBB86E-613E-4C2A-AEE8-91C508E53088Q38956091-C8E77333-C2CD-4903-B8A4-E86781249211Q39000212-CD23800A-260B-4156-8CD0-CBD64408B0B5Q39170189-8654ADD9-BC79-421F-AF1C-D630E136406FQ40869761-652997BA-57BA-43B6-B906-AE9D32400FEEQ41053501-356F6451-FF1C-42B3-B98B-A446B9FD0F53Q41196104-61A7FC78-7C7F-4857-ACB4-6071D54B488EQ41244010-221635BD-BA17-46CA-9C37-9084AF7DBFABQ43512294-A1F43545-5949-4F21-B7FA-131D6D2856CDQ47270129-1B6A72F0-F219-4F88-9E0C-B467CEA22658Q47869784-D07F73EA-C280-47A0-9138-6693B151F944
P2860
Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Hepatic artery chemoembolizati ...... cinoid tumor: lessons learned.
@en
Hepatic artery chemoembolizati ...... cinoid tumor: lessons learned.
@nl
type
label
Hepatic artery chemoembolizati ...... cinoid tumor: lessons learned.
@en
Hepatic artery chemoembolizati ...... cinoid tumor: lessons learned.
@nl
prefLabel
Hepatic artery chemoembolizati ...... cinoid tumor: lessons learned.
@en
Hepatic artery chemoembolizati ...... cinoid tumor: lessons learned.
@nl
P2093
P1476
Hepatic artery chemoembolizati ...... cinoid tumor: lessons learned.
@en
P2093
Bryan Palmer
Dori Klemanski
E Christopher Ellison
Edward W Martin
Gregory Guy
Hooman Khabiri
Joseph J Pinzone
Manisha H Shah
Mark Bloomston
Osama Al-Saif
P2888
P304
P356
10.1007/S11605-007-0089-Z
P577
2007-03-01T00:00:00Z